Transactions in own shares
Centrica plc
30 May 2023
Centrica plc announces that today it purchased (through Merrill Lynch International) 3,000,000 Centrica plc ordinary shares of 6 14/81 pence each at a price of 120.5169 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme announced on 5 April 2023 and effected in accordance with the non-discretionary agreement entered into with Merrill Lynch International, as announced on 5 April 2023.
Since 5 April 2023, Centrica has purchased 69,493,819 ordinary shares at a cost (excluding dealing and associated costs) of £79,216,320.11.
Following the above purchase, Centrica plc holds 269,404,166 ordinary shares in treasury, and has 5,638,441,972 ordinary shares in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.
Transaction details: Centrica plc ordinary shares of 6 14/81 pence each
|
Issuer name: |
Centrica plc |
|
ISIN: |
GB00B033F229 |
|
Intermediary name: |
Merrill Lynch International |
|
Intermediary Code: |
MLILGB3LESF |
|
Currency: |
GBP |
Aggregated information
|
Date of purchase: |
30 May 2023 |
|
Number of ordinary shares purchased: |
3,000,000 |
|
Highest price paid: |
121.9500p |
|
Lowest price paid: |
118.9000p |
|
Volume weighted average price paid per share: |
120.5169p |
Disaggregated information
The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.
Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/0770B_1-2023-5-30.pdf
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
